- Home
- BBIO vs TTD Comparison
BBIO vs TTD Comparison
Compare BBIO & TTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | TTD |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 13.0B |
| IPO Year | 2019 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BBIO | TTD |
|---|---|---|
| Price | $73.82 | $20.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 34 |
| Target Price | ★ $85.43 | $46.63 |
| AVG Volume (30 Days) | 1.6M | ★ 17.3M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 0.90 |
| Revenue | $502,076,000.00 | ★ $2,896,284,000.00 |
| Revenue This Year | $88.16 | $14.01 |
| Revenue Next Year | $74.13 | $12.63 |
| P/E Ratio | ★ N/A | $22.99 |
| Revenue Growth | ★ 126.26 | 18.47 |
| 52 Week Low | $30.08 | $20.38 |
| 52 Week High | $84.94 | $91.45 |
Technical Indicators
Market Signals| Indicator | BBIO | TTD |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 33.25 |
| Support Level | $69.62 | N/A |
| Resistance Level | $78.20 | $28.59 |
| Average True Range (ATR) | 2.66 | 1.24 |
| MACD | 0.41 | -0.06 |
| Stochastic Oscillator | 78.53 | 9.59 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.